- Home
- AIRI vs EVGN Comparison
AIRI vs EVGN Comparison
Compare AIRI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRI
- EVGN
- Stock Information
- Founded
- AIRI 1979
- EVGN 1999
- Country
- AIRI United States
- EVGN Israel
- Employees
- AIRI N/A
- EVGN N/A
- Industry
- AIRI Military/Government/Technical
- EVGN Agricultural Chemicals
- Sector
- AIRI Industrials
- EVGN Industrials
- Exchange
- AIRI Nasdaq
- EVGN Nasdaq
- Market Cap
- AIRI 13.5M
- EVGN 10.9M
- IPO Year
- AIRI N/A
- EVGN N/A
- Fundamental
- Price
- AIRI $2.92
- EVGN $1.14
- Analyst Decision
- AIRI
- EVGN Strong Buy
- Analyst Count
- AIRI 0
- EVGN 1
- Target Price
- AIRI N/A
- EVGN $3.50
- AVG Volume (30 Days)
- AIRI 31.4K
- EVGN 47.5K
- Earning Date
- AIRI 11-14-2025
- EVGN 11-20-2025
- Dividend Yield
- AIRI N/A
- EVGN N/A
- EPS Growth
- AIRI N/A
- EVGN N/A
- EPS
- AIRI N/A
- EVGN N/A
- Revenue
- AIRI $50,031,000.00
- EVGN $8,016,000.00
- Revenue This Year
- AIRI N/A
- EVGN N/A
- Revenue Next Year
- AIRI $3.53
- EVGN $12.35
- P/E Ratio
- AIRI N/A
- EVGN N/A
- Revenue Growth
- AIRI N/A
- EVGN 7.19
- 52 Week Low
- AIRI $2.77
- EVGN $0.95
- 52 Week High
- AIRI $4.89
- EVGN $2.42
- Technical
- Relative Strength Index (RSI)
- AIRI 45.24
- EVGN 43.43
- Support Level
- AIRI $2.77
- EVGN $1.08
- Resistance Level
- AIRI $2.96
- EVGN $1.26
- Average True Range (ATR)
- AIRI 0.11
- EVGN 0.07
- MACD
- AIRI -0.00
- EVGN -0.01
- Stochastic Oscillator
- AIRI 54.17
- EVGN 25.00
About AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.